Article

Blood molybdenum level as a marker of cancer risk among BRCA1 carriers

2024-06-04

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose:</bold>A large proportion of ovarian and breast cancer cases are due to genetic predisposition. Women with a mutation in the <italic>BRCA1</italic> gene have an up to an 80% chance of developing breast cancer and 40% chance of developing ovarian cancer. No studies to date assess exposure to molybdenum and cancer risk. The purpose of our study was to see if exposure to moly...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f7d319dc-d77c-5537-a771-6fcc11119461
DOI: 10.21203/rs.3.rs-4430332/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Blood molybdenum level as a marker of cancer risk among BRCA1 carriersDOI 10.21203/rs.3.rs-4430332/v1Read

Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers.Semantic proximity Read

Potential Association of Mitochondrial Haplogroups and A8860G Mutation with Breast Cancer RiskSemantic proximity Read

Cancer Screening in Angolan Individuals Using Tumor Marker Tests at Mediag, Luanda-AngolaSemantic proximity Read

Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.Semantic proximity Read

Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer.Semantic proximity Read

[Germline mutations and breast cancer risk].Semantic proximity Read

ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.Semantic proximity Read

Diagnostic algorithm for identification of individuals with hereditary predisposition to breast cancer.Semantic proximity Read